Literature DB >> 8624885

Association of multiple human papillomavirus types with vulvar neoplasias.

H Nagano1, H Yoshikawa, T Kawana, H Yokota, Y Taketani, H Igarashi, H Yoshikura, A Iwamoto.   

Abstract

OBJECTIVE: The purpose of this study was to clarify the association of multiple genital human papillomavirus (HPV) types with vulvar neoplasias.
METHODS: We examined vulvar neoplasias by the polymerase chain reaction (PCR) method, which can detect almost all genital HPV types sensitively (L1-PCR).
RESULTS: Eight HPV types (types 6, 11, 16, 18, 52, 53, 56, and 68) were detected in 52 of 53 (98.1%) vulvar condylomas; 2 HPV types (types 16 and 18) were detected in all 6 Grade-3 vulvar intraepithelial neoplasias; and 5 HPV types (types 6, 16, 18, 51, and 56) were detected in 8 of 11 (72.7%) invasive vulvar carcinomas. Detection of HPV types 52, 53, 56, and 68 in vulvar condylomas and detection of HPV types 51 and 56 in vulvar carcinomas are the first examples ever reported.
CONCLUSION: This study suggests that more HPV types are associated with the generation of vulvar neoplasias than was thought to be the case up to now.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624885     DOI: 10.1111/j.1447-0756.1996.tb00927.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  9 in total

Review 1.  Human papillomavirus infections in primary care.

Authors:  Folashade Ogunmodede; Steven H Yale; Bruce Krawisz; Gregory C Tyler; Anthony C Evans
Journal:  Clin Med Res       Date:  2007-12-17

2.  Cigarette smoke stimulates VEGF-C expression in cervical intraepithelial neoplasia (CIN) 1 and 2 lesions.

Authors:  Morihiko Inamine; Yutaka Nagai; Akira Mitsuhashi; Satoru Nagase; Nobuo Yaegashi; Hiroyuki Yoshikawa; Yoichi Aoki
Journal:  Int J Clin Oncol       Date:  2011-09-27       Impact factor: 3.402

3.  Clinical significance of hWAPL polymorphisms in the risk of cervical carcinogenesis.

Authors:  Osamu Nunobiki; Daisuke Sano; Sakae Hata; Toshitada Ogasawara; Masatsugu Ueda
Journal:  Hum Cell       Date:  2018-01-23       Impact factor: 4.174

4.  Subsequent risks for cervical precancer and cancer in women with low-grade squamous intraepithelial lesions unconfirmed by colposcopy-directed biopsy: results from a multicenter, prospective, cohort study.

Authors:  Koji Matsumoto; Yasuo Hirai; Reiko Furuta; Naoyoshi Takatsuka; Akinori Oki; Toshiharu Yasugi; Hiroo Maeda; Akira Mitsuhashi; Takuma Fujii; Kei Kawana; Tsuyoshi Iwasaka; Nobuo Yaegashi; Yoh Watanabe; Yutaka Nagai; Tomoyuki Kitagawa; Hiroyuki Yoshikawa
Journal:  Int J Clin Oncol       Date:  2011-07-13       Impact factor: 3.402

5.  Germline polymorphisms of glutathione-S-transferase GSTM1, GSTT1 and p53 codon 72 in cervical carcinogenesis.

Authors:  Masatsugu Ueda; Eisaku Toji; Osamu Nunobiki; Naomi Sato; Shinji Izuma; Kiyo Torii; Yoshiaki Okamoto; Sadamu Noda
Journal:  Hum Cell       Date:  2010-10-04       Impact factor: 4.174

6.  GSTM1, GSTT1, and NQO1 polymorphisms in cervical carcinogenesis.

Authors:  Osamu Nunobiki; Masatsugu Ueda; Hikari Akise; Shinji Izuma; Kiyo Torii; Yoshiaki Okamoto; Ichiro Tanaka; Sadamu Noda; Kyoko Akashi; Taro Higashida
Journal:  Hum Cell       Date:  2015-02-20       Impact factor: 4.174

7.  ALDH2 polymorphism for the risk of cervical carcinogenesis.

Authors:  Osamu Nunobiki; Daisuke Sano; Kyoko Akashi; Taro Higashida; Toshitada Ogasawara; Hikari Akise; Shinji Izuma; Kiyo Torii; Yoshiaki Okamoto; Ichiro Tanaka; Masatsugu Ueda
Journal:  Hum Cell       Date:  2016-02-03       Impact factor: 4.174

8.  Genetic Polymorphism of Cancer Susceptibility Genes and HPV Infection in Cervical Carcinogenesis.

Authors:  Osamu Nunobiki; Masatsugu Ueda; Eisaku Toji; Michiko Yamamoto; Kyoko Akashi; Naomi Sato; Shinji Izuma; Kiyo Torii; Ichiro Tanaka; Yoshiaki Okamoto; Sadamu Noda
Journal:  Patholog Res Int       Date:  2011-05-31

9.  Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?

Authors:  Koji Matsumoto; Hiroo Maeda; Akinori Oki; Naoyoshi Takatsuka; Toshiharu Yasugi; Reiko Furuta; Ranko Hirata; Akira Mitsuhashi; Kei Kawana; Takuma Fujii; Takashi Iwata; Yasuo Hirai; Masatoshi Yokoyama; Nobuo Yaegashi; Yoh Watanabe; Yutaka Nagai; Hiroyuki Yoshikawa
Journal:  Cancer Sci       Date:  2015-09-25       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.